HeartFlow
NASDAQ: HTFLRedwood City, US · Delaware corporation · 868 employees on LinkedIn · 8 known investors
Find your way into HeartFlow
2,348 people in our graph share verified history with the HeartFlow team — schools, employers, funds. One of them is your warm intro.
Deep Nisharunlockedknows Charles A. Taylor · together at Stanford University (overlapped)
×11knows the team · via Stanford University
Heartflow provides an AI-based analysis that converts a coronary CTA scan into a personalized 3D model of the heart, assessing anatomy and physiology to help diagnose and manage coronary artery disease (CAD). Its platform, Heartflow One, is used by cardiologists and clinicians to guide diagnosis and treatment decisions for patients.
Founders & leadership
CK
Christopher K. ZarinsinCo-founder · Senior Advisor for Clinical Science
CA
Charles A. TaylorinFounderDr. Charles A. Taylor is founder and former Chief Technology Officer (2010–2021) and Chief Scientific Officer (2021–2023) of HeartFlow, which develops AI-based analysis tools for coronary artery disease diagnosis. He holds the W.A. "Tex" Moncrief, Jr., Chair in Computational Medicine at the University of Texas at Austin and previously served as an Associate Professor in Bioengineering and Surgery at Stanford University, with expertise in computational modeling of blood flow using medical imaging data.
NE
Nicky Espinosa HayesExecutive
JS
John StevensinCo-Founder, Board of Directors2019–2021
HB
H. Baird Radford, IIIExecutive
JF
John FarquharinPresident and Chief Executive Officer
Board
CT
TH
JL
Jeff LightcapBoard director
BU
Barry UphoffBoard director
PM
JD
Jesse Du BeyBoard director
Investors · 8
Bain Capital Life SciencesBoston
Blue Venture FundsChicago · $1M – $20M
Emergent Medical Partners, LLPSan Jose
Khosla VenturesMenlo Park · $5K – $50M
Lifeforce CapitalChevy Chase · $500K – $5M
Lotus CapitalCupertino
Silver Lake PartnersMenlo Park
US Venture PartnersMenlo Park · $500K – $10Mvia Casey Tansey · board
Reported raises · per SEC filings
Form D private placements$359.6M disclosed across 4 rounds · 2011–2019
▶$65MraisedJun 2019 · 9 investors · BiotechnologyRule 506(b)
▶$65MraisedJun 2019 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dana MeadExecutive Officer, Director
- Charles A. TaylorExecutive Officer, Director
- John StevensDirector
- Casey TanseyDirector
- Lonnie SmithDirector
- William WeldonDirector
- Kent WalkerDirector
- H. Baird Radford, IIIExecutive Officer
- Noemi C. EspinosaExecutive Officer
- Jeff LightcapDirector
- Offering amount
- $100M
- Amount sold
- $65M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$90MraisedDec 2017 · 2 investors · BiotechnologyRule 506(b)
▶$90MraisedDec 2017 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- KENT WALKERDirector
- CHARLES A. TAYLORExecutive Officer, Director
- JEFF LIGHTCAPDirector
- TOM HAWESDirector
- JOHN STEVENSExecutive Officer, Director
- LONNIE SMITHDirector
- BARRY UPHOFFDirector
- NOEMI C. ESPINOZAExecutive Officer
- CASEY TANSEYDirector
- H. BAIRD RADFORD, IIIExecutive Officer
- PHILIP M. YOUNGDirector
- CHRISTOPHER K. ZARINSExecutive Officer, Director
- WILLIAM WELDONDirector
- Offering amount
- $150M
- Amount sold
- $90M
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$99.9MraisedMay 2016 · 25 investors · BiotechnologyRule 506(b)
▶$99.9MraisedMay 2016 · 25 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lonnie SmithDirector
- Christopher K. ZarinsExecutive Officer, Director
- Casey TanseyDirector
- Tom HawesDirector
- Jeff LightcapDirector
- Barry UphoffDirector
- Charles A. TaylorExecutive Officer, Director
- Nicky Espinosa HayesExecutive Officer
- William WeldonDirector
- John StevensExecutive Officer, Director
- H. Baird Radford, IIIExecutive Officer
- Philip M. YoungDirector
- Kent WalkerDirector
- Offering amount
- $110.9M
- Amount sold
- $99.9M
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$104.7MraisedFeb 2014 · 29 investors · Other Health CareRule 506(b)
▶$104.7MraisedFeb 2014 · 29 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jesse Du BeyDirector
- Barry UphoffDirector
- Christopher K. ZarinsDirector
- Lonnie SmithDirector
- Thomas C. HawesDirector
- John StevensExecutive Officer, Director
- Jeff LightcapDirector
- Charles A. TaylorDirector
- Casey TanseyDirector
- Philip M. YoungDirector
- Offering amount
- $106.7M
- Amount sold
- $104.7M
- First sale
- Dec 2011
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Medscape72 shared keywordsMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
Vumedi54 shared keywordsVumedi operates a peer-to-peer video education platform where clinicians watch lectures and technique videos across dozens of medical specialties. It partners with academic institutions, hospitals, and life sciences companies to provide continuing medical education content to doctors.
Companies competing with HeartFlow for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does HeartFlow do?
- Heartflow provides an AI-based analysis that converts a coronary CTA scan into a personalized 3D model of the heart, assessing anatomy and physiology to help diagnose and manage coronary artery disease (CAD). Its platform, Heartflow One, is used by cardiologists and clinicians to guide diagnosis and treatment decisions for patients.
- Who founded HeartFlow?
- HeartFlow was founded by Christopher K. Zarins, Charles A. Taylor.
- Who are HeartFlow's investors?
- HeartFlow's investors include Bain Capital Life Sciences, Blue Venture Funds, Emergent Medical Partners, LLP, Khosla Ventures, Lifeforce Capital, Lotus Capital, Silver Lake Partners, US Venture Partners.
- How much funding has HeartFlow raised?
- HeartFlow has disclosed $359.6M raised across 4 rounds.
- Where is HeartFlow headquartered?
- HeartFlow is headquartered in Redwood City, US.